<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04966156</url>
  </required_header>
  <id_info>
    <org_study_id>21-5076.0</org_study_id>
    <nct_id>NCT04966156</nct_id>
  </id_info>
  <brief_title>Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT</brief_title>
  <official_title>A Longitudinal Multidimensional Cancer Rehab Program for Patients Undergoing Allogenic Bone and Marrow Transplantation (CaRE-4-alloBMT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, transplantation centers across North America generally do not offer longitudinal&#xD;
      rehabilitation programs and research is urgently needed to test the acceptability and&#xD;
      effectiveness of these programs using innovative delivery strategies that have the potential&#xD;
      for future scalability and to understand the associated costs. Through a strong collaboration&#xD;
      between the PM Cancer Rehabilitation and Survivorship (CRS) and alloBMT teams, the principal&#xD;
      investigators developed an innovative multicomponent rehabilitation intervention for patients&#xD;
      undergoing alloBMT (CaRE-4-alloBMT).&#xD;
&#xD;
      CaRE-4-alloBMT uses a person- centred strategy and a multidimensional approach targeting&#xD;
      physical activity, nutrition, psychosocial distress and promoting self-management skills.&#xD;
      Innovative components of CaRE-4-alloBMT include:1) Individualized progressive exercise&#xD;
      prescriptions developed and monitored by CRS registered kinesiologists and supported with a&#xD;
      web/mobile application (Physitrack) that allows customizable exercise prescriptions, tracking&#xD;
      of exercise completion, and video tutorials; 2) Individualized nutrition plans and stepped&#xD;
      stratified care (education, counselling, intervention) based on nutritional status and&#xD;
      delivered by registered dietitians (alloBMT and CRS). 3) On-line e-modules (developed in&#xD;
      collaboration with PM Oncology Education) provide interactive education to promote&#xD;
      self-management skills on crucial topics; 4) Remote monitoring using FitbitTM devices to&#xD;
      monitor patients physical activity, caloric intake, and sleep for duration of the program; 5)&#xD;
      Remote clinical support: Pre/Post discharge, patients will have scheduled (PHS) remote&#xD;
      check-ins and health coaching sessions with a member of the CRS team (phone or MS Teams&#xD;
      video).&#xD;
&#xD;
      Objectives: i) To test the feasibility and safety of CaRE-4-alloBMT plus standard best&#xD;
      practice cancer care compared to standard best practice cancer care alone; ii) To assess the&#xD;
      preliminary efficacy of CaRE-4-alloBMT on physical function, disability, nutritional status,&#xD;
      distress, QoL, healthcare utilization, and survival and estimate program return on&#xD;
      investment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1.0 BACKGROUND: Allogeneic blood and marrow transplantation (alloBMT) is a curative treatment&#xD;
      for many hematologic cancers and its use has increased rapidly over the past decade. While&#xD;
      effective, alloBMT is associated with numerous treatment-related physical and psychosocial&#xD;
      side effects, reduced physical functioning, and worsening nutritional status which are&#xD;
      associated with increased risk of complications (i.e. infections, drug toxicity, weight loss,&#xD;
      graft failure &amp; graft-versus-host disease), significant early and late treatment related&#xD;
      mortality, and can profoundly affect quality of life (QoL).&#xD;
&#xD;
      As a result, there have been calls for increased attention to the management of adverse&#xD;
      effects associated with alloBMT with the goal to minimize dysfunction, maximize well-being&#xD;
      and QoL, and reduce treatment-related mortality.&#xD;
&#xD;
      Cancer rehabilitation is now considered an essential component of cancer care and focuses on&#xD;
      prevention and treatment of the adverse effects of cancer and treatment and to optimize&#xD;
      functional status and QoL. Embedding multidimensional longitudinal (pre to post transplant)&#xD;
      rehabilitation programs that focus on exercise, nutrition and teaching self-management skills&#xD;
      as a standard part of treatment for individuals undergoing alloBMT has potential to mediate&#xD;
      the significant adverse effects, improve survival, and reduce burden on the healthcare&#xD;
      system. While patients typically receive some in-patient rehabilitation, this is a small part&#xD;
      of the alloBMT pathway and services are quite limited. Currently, transplantation centers&#xD;
      across North America generally do not offer longitudinal rehabilitation programs and research&#xD;
      is urgently needed to test the acceptability and effectiveness of these programs using&#xD;
      innovative delivery strategies that have the potential for future scalability and to&#xD;
      understand the associated costs. In response, through a strong collaboration between the PM&#xD;
      Cancer Rehabilitation and Survivorship (CRS) and alloBMT teams, the principal investigators&#xD;
      developed an innovative multicomponent rehabilitation intervention for patients undergoing&#xD;
      alloBMT (CaRE-4-alloBMT).&#xD;
&#xD;
      2.0 PROGRAM DESCRIPTION (see Appendix 1): CaRE-4-alloBMT is a longitudinal 6-month&#xD;
      rehabilitation program (peri to post transplant) adapted from an existing evidence-based and&#xD;
      effective model developed by the CRS team (CaRE@ELLICSR and CaRE@Home). The program is&#xD;
      informed by established behaviour change theory and harnesses current and emerging eHealth&#xD;
      technologies to reduce barriers to accessing and providing cancer rehabilitation.&#xD;
      CaRE-4-alloBMT uses a person- centred strategy and a multidimensional approach targeting&#xD;
      physical activity, nutrition, psychosocial distress and promoting self-management skills.&#xD;
      Innovative components of CaRE-4-alloBMT include:&#xD;
&#xD;
        1. Individualized progressive exercise prescriptions developed and monitored by CRS&#xD;
           registered kinesiologists and supported with a web/mobile application (Physitrack) that&#xD;
           allows customizable exercise prescriptions, tracking of exercise completion, and video&#xD;
           tutorials. The initial personalized exercise program will be given to a participant&#xD;
           following the initial assessment. A program will be created based on the specific needs&#xD;
           and physical condition of each participant. The participant will receive the detailed&#xD;
           exercise program via Physitrack (includes exercise description and videos of each&#xD;
           exercise). Each exercise program will contain cardiovascular and strength training as&#xD;
           well as stretching exercises. The exercise program will be revised and progressions will&#xD;
           be added based on the individual's needs after the follow-up assessments or during the&#xD;
           scheduled check-ins between assessments. Check-ins are scheduled as follows:&#xD;
&#xD;
             -  At 2 and 4 weeks after initial assessment&#xD;
&#xD;
             -  8 weekly check-ins following discharge&#xD;
&#xD;
             -  At 10 and 12 weeks following discharge The participant can contact the&#xD;
                Kinesiologist by e-mail at any point during the program.&#xD;
&#xD;
        2. Individualized nutrition plans and stepped stratified care (education, counselling,&#xD;
           intervention) based on nutritional status and delivered by registered dietitians&#xD;
           (alloBMT and CRS). As part of standard of care, all patients receive a nutrition&#xD;
           assessment and their caloric intake goals are set. Those in the INT arm (CaRE-4-alloBMT&#xD;
           plus usual care group) will receive additional nutritional education through the&#xD;
           e-modules and monitoring of caloric intake through the Fitbit. They will also have&#xD;
           access to meal preparation and recipes through ellicsrkitche.ca. Patients can track&#xD;
           their nutritional intake on their Fitbit device and this data will be monitored weekly&#xD;
           by the RKin. Patients who falls below 50% of their goals (based on intake assessment)&#xD;
           will flagged to the RD for follow up.&#xD;
&#xD;
        3. On-line e-modules (developed in collaboration with PM Oncology Education) provide&#xD;
           interactive education to promote self-management skills on crucial topics (i.e. stress&#xD;
           management, nutrition, managing common symptoms). There will be 9 online e-modules:&#xD;
&#xD;
             -  Introduction: Getting started&#xD;
&#xD;
             -  Eat and Cook for Wellness&#xD;
&#xD;
             -  Exercise&#xD;
&#xD;
             -  Manage Your Emotions&#xD;
&#xD;
             -  Reduce Fatigue&#xD;
&#xD;
             -  Being Mindful&#xD;
&#xD;
             -  Boost Your Brain Health&#xD;
&#xD;
             -  Stay Connected&#xD;
&#xD;
             -  Planning for the Future Participants will be asked to complete all 9 modules. Each&#xD;
                module should take between 20-30 minutes to complete. Participants can go through&#xD;
                these modules at their own pace. Patients will receive a link for the online&#xD;
                modules. Patients will be able to access the module by entering their e-mail&#xD;
                address and creating their own unique password.&#xD;
&#xD;
        4. Remote monitoring using FitbitTM devices to monitor patients physical activity, caloric&#xD;
           intake, and sleep for duration of the program. CRS and alloBMT clinicians will have&#xD;
           access to real-time Fitbit data through the clinical dashboard (developed in&#xD;
           collaboration with TECHNA). The Fitbit is also known to promote behaviours change and&#xD;
           allows for self-monitoring and feedback. Participants will be asked to wear the Fitbit&#xD;
           for the duration of the study. Participants will only need to add their meals to monitor&#xD;
           their nutrition. No other action is required from the participants once the account has&#xD;
           been created. This will replace the paper based food diary they must keep (standard of&#xD;
           care). The account for the participant will be created by the RA or RKin and the&#xD;
           participant will then be able to access the app via an email link. The RA or RKin can&#xD;
           assist/provide support to the participant as needed to access the app. If the&#xD;
           participant is unable to download or use the app a detailed print out of their exercise&#xD;
           program will be provided.&#xD;
&#xD;
           The following information will be required to create an account:&#xD;
&#xD;
             -  First name&#xD;
&#xD;
             -  Last name (participant study number will be entered in this field&#xD;
&#xD;
             -  Year of birth&#xD;
&#xD;
             -  Email address Both the participant and Kinesiology team will have access to this&#xD;
                information but the account information is not visible to third parties. Physitrack&#xD;
                provides links to the privacy policy and terms of use/agreement and is available&#xD;
                for the participant to review as needed.&#xD;
&#xD;
        5. Remote clinical support: Pre/Post discharge, patients will have scheduled (PHS) remote&#xD;
           check-ins and health coaching sessions with a member of the CRS team (phone or MS Teams&#xD;
           video). These occur in week 2,4 (pre) and 1-8,10,12 (post-discharge).&#xD;
&#xD;
      Frequency of check-ins and what will be discussed: Check-ins are by telephone or MSteams&#xD;
      video and scheduled as follows:&#xD;
&#xD;
        -  At 2 and 4 weeks after initial assessment (pre-BMT admission)&#xD;
&#xD;
        -  Weeks 1-8, 10 and 12 post-discharge (post-BMT dischange)&#xD;
&#xD;
           - Check-ins discussion using motivational interviewing techniques and focus on&#xD;
&#xD;
        -  Adherence to exercise program&#xD;
&#xD;
        -  Changes to exercise program based on participant's needs&#xD;
&#xD;
        -  Module completion&#xD;
&#xD;
        -  Answering participants questions The program strongly aligns with the SUNDAE framework&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be informed when consented that they will be grouped into one of two (control or intervenion) study groups for the duration of the study. Following their baseline assessment, patients will be randomized (1:1 stratified by age and clinical frailty score at pre-transplant consultation).</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>biostatician will provide the randomized grouping for each of the participants.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Drop-out rates as a measure of feasibility</measure>
    <time_frame>6 months</time_frame>
    <description>Number of patients who complete the study/ drop-out will be used to identify feasibility of the intervenion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient preference as assessed during clinical support as a measure of feasibiity</measure>
    <time_frame>6 months</time_frame>
    <description>Check-ins with health coach during assessments will be used to identify intervention acceptability/preference.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measuring safety as assessed during one-on-one interviews with health coach - this wll be (analyzed as qualitative data) done over MS Teams and will be a conversational question and answer format.</measure>
    <time_frame>6 months</time_frame>
    <description>Patients will be checking-in at specific timepoints with a health coach to discuss their preference/challenges with intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disability assessment schedule</measure>
    <time_frame>6 months</time_frame>
    <description>World Health Organization Disability Assessment Schedule 2.0. The scale is (0-4) for a total score from 0-48 and the larger the value the worse the outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>36 items short form health survey</measure>
    <time_frame>6 months</time_frame>
    <description>self reported measure of overall health - total score: 0-100 and the higher the score, the better the health state (less disability)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluating nutritional status based on caloric intake</measure>
    <time_frame>6 months</time_frame>
    <description>using data from fitbit worn by patient to record their daily caloric intake.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Using the Body Mass Indext to measure nutritional status</measure>
    <time_frame>6 months</time_frame>
    <description>Body Mass Index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of nutritional status by using the Patient Generated Subjective Global Assessment</measure>
    <time_frame>6 months</time_frame>
    <description>Patient-reported instrument for assessment of nutrition status in patients with cancer - Typical scores range from 0-35 with a higher score reflecting a greater risk of malnutrition and scores â‰¥9 indicating a critical need for nutrition intervention and symptom management.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Anxiety Disorder assessment</measure>
    <time_frame>6 months</time_frame>
    <description>Measure of General Anxiety and distress - total score: 0-21 and the cut-offs are: 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Assessment of Cancer Therapy for Bone Marrow Transplant</measure>
    <time_frame>6 months</time_frame>
    <description>a measure of quality of life - total score of 0-196 with a higher scores for the scales and subscales indicate better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure of the level of healthcare utilization by patient</measure>
    <time_frame>6 months</time_frame>
    <description>clinic chart details for days in hospital, readmission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>measure of overall survival</measure>
    <time_frame>6 months</time_frame>
    <description>will be interpretted from the quantitative and qualitative date extracted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Euroqol 5D</measure>
    <time_frame>6 months</time_frame>
    <description>Health related quality of life - The maximum score of 1 indicates the best health state, by contrast with the scores of individual questions, where higher scores indicate more severe or frequent problems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 minute walk test</measure>
    <time_frame>6 months</time_frame>
    <description>measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>grip strength tests</measure>
    <time_frame>6 months</time_frame>
    <description>measures the muscular strength or the maximum force/tension generated by one's forearm muscles</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sit-to-stand test</measure>
    <time_frame>6 months</time_frame>
    <description>measurement that assesses functional lower extremity strength in older adults</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Allogeneic Disease</condition>
  <condition>Hematologic Cancer</condition>
  <condition>Cancer Rehabilitation</condition>
  <arm_group>
    <arm_group_label>Usual care group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No change to patient's usual care at Princess Margaret Cancer Centre.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CaRE-4-allBMT plus usual care</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a longitudinal 6-month rehabilitation program that uses a person- centred strategy and a multidimensional approach targeting physical activity, nutrition, psychosocial distress and promoting self-management skills.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CaRE-4-alloBMT plus usual care group</intervention_name>
    <description>CaRE-4-alloBMT uses emerging eHealth technologies to reduce barriers to accessing and providing cancer rehabilitation which includes: 1) Individualized progressive exercise prescriptions that allows customizable exercise prescriptions, tracking of exercise completion, and video tutorials; 2) Individualized nutrition plans and stepped stratified care such as education, counselling, intervention based on nutritional status and delivered by registered dietitians; 3) On-line e-modules provide interactive education to promote self-management skills for stress management, nutrition, managing common symptoms, etc.; 4) Remote monitoring using FitbitTM devices to monitor patients physical activity, caloric intake, and sleep for duration of the program. CRS and alloBMT clinicians will have access to real-time Fitbit data through our clinical dashboard; 5) Remote clinical support: check-ins and health coaching sessions with a member of the CRS team (phone or MS Teams video).</description>
    <arm_group_label>CaRE-4-allBMT plus usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Must have received a hematologic cancer diagnosis&#xD;
&#xD;
          -  Awaiting alloBMT&#xD;
&#xD;
          -  Able to communicate in English&#xD;
&#xD;
          -  Able to access online study material (Physitrack and education e-modules).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not meeting the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer M Jones, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charmaine A Silva, MSc</last_name>
    <phone>4167160582</phone>
    <email>charmaine.silva@uhn.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paty Lopez, MSc</last_name>
    <email>Paty.Lopez@uhnresearch.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Princess Margaret Cancer Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paty Lopez, MSc</last_name>
      <email>paty.lopez@uhnresearch.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2021</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematologic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

